Acetylator polymorphism in human colorectal carcinoma.

Abstract excerpt

Acetylator phenotype has been determined using sulfamethazine in 109 patients histologically diagnosed with colorectal carcinoma (resected in 74 patients by the time of the study) and in 96 age-matched controls. Fifty-five % of patients and 58.3% of controls were classified as slow acetylators (chi 2 = 0.11, not significant). No differences were observed in the distribution of acetylator phenotype when analyzing...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acetylation
• Share to Aged
• Share to Colorectal Neoplasms